Research Reflections: Siponimod Trial Results MStranslate November 21, 2019 Clinical Trials, Research, Treatments 1 Comment In April 2018, we published the below video to our Facebook page, exploring and discussing the results of the Phase III trial of Mayzent (siponimod). With this therapy recently approved for the treatment of secondary progressive multiple sclerosis (SPMS) in Australia, we thought it an appropriate time to revisit this feature. One Response Leave a Reply Cancel ReplyYour email address will not be published.CommentName* Email* Website Notify me of follow-up comments by email. Notify me of new posts by email. Δ This site uses Akismet to reduce spam. Learn how your comment data is processed.
